STACLEAR
Designed For:
Ophthalmologists
Outsourcing Facilities
Ophthalmic Drug Companies
WHY INVENT AN INTRAVITREAL SYRINGE?
In 2018, the Food & Drug Administration (FDA) issued more stringent guidelines for compounding drugs for intraocular injections, adding regulatory risk.
Floaters In The Eye Reported
In late 2016, the American Society of Retina Specialist (ASRS) alerted its members to the risk of floaters and intraocular pressure caused by liquid silicone oil -- the lubricant used in generic insulin syringes.
The FDA Steps In For Patient Safety
Insurance companies required retina specialists have their patients sign a liability waiver before the procedure in view of this new liability risk.
The Industry Responded
Why Stop at One Problem, When We Can Fix Them All?
Our team worked closely with ophthalmologists and compounding pharmacies to understand ALL their requirements:
Smoother plunger movement
High accuracy large markings
Reduced dead space
Optimized packaging for customer needs
StaClear Offers 3 Types of Fillable Intravitreal Syringes: Attached Needle, Luer Lock & Luer Slip
StaClear
Attached Needle Syringe (SC250AN)
StaClear
Luer Slip Syringe (SC250LS)
StaClear
Luer Lock Syringe (SC250LL)
StaClear Syringes Are Packaged in
Convenience Trays
Each StaClear box holds 2 trays.
Luer Slip
Convenience Tray holds 60 syringes
Luer Lock
Convenience Tray holds 50 syringes
StaClear Luer Lock syringes are also available in an individual unit pack format.
Attached Needle
Convenience Tray holds 50 syringes
5 Reasons Why Retina Specialists Choose StaClear For Ophthalmic Drug Delivery:
OPTIMIZED DESIGN: All 3 StaClear Syringes (Attached Needle, Luer Lock & Luer Slip) are designed to to reduce dead space — saving up to $10-15 of drug wastage.
CONTROLLED INJECTION EXPERIENCE: Elastomer piston ensures sealing integrity -- a known risk in silicone-free syringes.
EASY-TO-READ LARGE GRADUATION MARKS: This enables precision dosing (0.25ml syringe with 0.01ml graduations). Our Luer Lock syringe includes a new 0.025 mL graduation mark!
IMPROVED ACCURACY: vs. larger 1ml syringe types.
OPHTHALMIC-SAFE MATERIALS: Meets chemical and biocompatibility standards for ophthalmic use.
The StaClear Team
-
“After years of R&D, it is gratifying to see significant market interest for StaClear, and receive so much positive client feedback.”
VINAY SAKHRANI - Founder & CEO
-
"We have helped many device companies with their R&D challenges, but the StaClear product is my absolute favorite."
JACKSON THORNTON - Co-Founder & Director of Technology
-
"One of my mentors needs an intravitreal injection monthly for wet AMD. This syringe to market is personally important to me."
NEESHA MIRCHANDANI- Director of Communications
-
“Patients first. Then use Quality as a tool to meet physician expectations. That's what makes us different from every other ophthalmic drug delivery device."
PAUL J STOKES - Quality Manager
StaClear’s patented technology is a lubricant coating anchored to the walls of the syringe versus liquid silicone oil in generic syringes that has been linked to adverse outcomes.
Why Does the StaClear Luer Lock Syringe Include a 0.025 mL Graduation Mark?
"An ophthalmic drug discovery company was struggling to find a delivery device with a 0.025 mL graduation to enable micro-dosing for an innovative intravitreal product. Our core values are responsiveness and innovation, so we were happy to help them by adding it to the StaClear Luer Lock syringe.”
- Jackston Thornton, PhD, Co-Founder & Director, Technology, StaClear, Inc.
This Research Was Funded by National Eye Institute.
The National Eye Institute (through its SBIR grant program) championed and funded this important research. Thanks to its support, StaClear is the first syringe designed for ophthalmologists.
Have Questions About StaClear? Get in Touch.
I’m Vinay Sakhrani, CEO at StaClear. We are here to answer your questions about StaClear. We typically respond within 1 business day.